The discovery of penicillin dates back to 1928, founded by Sir Alexander Fleming. Since then it has saved the lives of millions suffering with life-threatening infections on a global scale. Antibiotics work by killing bacteria or preventing them from reproducing and spreading, such as pneumonia and sepsis. Antibiotics aren’t effective against viral infections however, such as the common cold, flu, some coughs and sore throats. [1]

A lot has changed in almost 100 years!

Due to the popularity and diversity of antibiotics of all types, bacteria have developed mechanisms to escape the effects of antibiotics – they have become resistant. This is a huge threat to society and has forced medical practitioners and scientists to develop and uncover new ways of treating infection or to limit who and how many get antibiotics in an effort to slow down the rate that bacteria become resistant. This can be further exacerbated if you do not finish a course of antibiotics, creating an opportunity for bacteria to survive a short dosage of antibiotics and become tolerant or resistant to them.

Anti-resistance must be stopped

According to the researchers, overuse of antibiotics is the main cause of antibiotic resistance. If we combine an antibiotic with a helper compound, that enhances the effect of the antibiotic, we need less antibiotic to achieve the same effect. This may contribute to the development of fewer resistant bacteria, says Janne Kudsk Klitgaard. [2]

Medicinal Cannabis & Antibiotics

There is a variety of scientific evidence regarding how CBD makes antibiotics more effective. A research team from the University of Southern Denmark, published a research paper where this effect has been observed when combined with antibiotics.

“When we combined CBD and antibiotics, we saw a more powerful effect than when treating with antibiotics alone. So, in order to kill a certain number of bacteria, we needed less antibiotics, they say.” [2]

The research team found that cannabis compound cannabidiol (CBD) may act as a helper compound to boost the effectiveness of antibiotics against drug-resistant Gram-positive bacteria. A new finding and novel treatment for antibiotic resistant bacteria.

Medicinal cannabis continues to deliver novel therapies for a variety of chronic conditions and diseases. This news is a major step forward in the fight against resistant bacteria and the issue of antibiotic longevity.

The new discoveries of clinical research focused on medicinal cannabis is increasing each day but it is still in its infancy and in some cases lacks trial data to support observations and hypothesis. Here in the UK, a trial was announced that will target 20,000 patients, they will be given medicinal cannabis over a two-year period in an initiative that aims to create the largest body of evidence on the drug in Europe. [3] This is extremely exciting news for the industry as cannabis therapies with empirical data to support their benefits will be widely available.

Why we care!

At Eco Equity, we are extremely passionate about cannabis research and raising awareness. Our aim is to become pioneers in this science with our knowledge of the plant and our desire to help more patients seek effective treatment at a quicker pace than now. Follow us on social media to keep up to date with our project!